13 completed, 5 terminated, 1 unknown. 19 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 19 | Completed 13, Terminated 5, Unknown 1 |
Follow ThromboGenics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment of Post-Ocriplasmin Therapy Vitreolysis Induced Subretinal Fluid With Eplerenone (Mineralocorticoid Antagonists) Eplerenone - Vitreomacular Traction, Subretinal Edema | Phase 2 | Terminated | Wagner Macula & Retina Center | 2 | 2019-10-04 | 2021-01-08 |
| A Study to Evaluate THR-317 Treatment for Macular Telangiectasia Type 1 (MacTel 1) THR-317 8mg - Retinal Telangiectasis, Idiopathic Juxtafoveal Retinal Telangiectasia | Phase 2 | Completed | ThromboGenics | 8 | 2018-09-18 | 2020-09-02 |
| A Study to Evaluate the Safety and Efficacy of THR-317 for the Treatment of Diabetic Macular Oedema (DME) Anti-PlGF recombinant monoclonal antibody, 4mg dose, Anti-PlGF recombinant monoclonal antibody, 8mg dose - Diabetic Retinopathy, Macular Edema | Phase 2 | Completed | ThromboGenics | 49 | 2016-12-22 | 2018-04-17 |
| A Study to Evaluate the Efficacy and Safety of Ocriplasmin in Inducing Total PVD in Subjects With NPDR ocriplasmin 0.0625mg, ocriplasmin 0.125mg, Sham injection - Diabetic Retinopathy, Posterior Vitreous Detachment | Phase 2 | Terminated | ThromboGenics | 48 | 2015-12-01 | 2020-12-16 |
| Single IV Administration of TB-402 for Prophylaxis of Venous Thromboembolic Events (VTE) After Total Hip Replacement Surgery TB-402, Rivaroxaban - Prophylaxis of Venous Thromboembolic Events | Phase 2 | Completed | ThromboGenics | 632 | 2011-04-01 | 2012-08-23 |
| The Purpose of This Study is to Evaluate the Pharmacokinetic Properties of Intravitreal Ocriplasmin Prior to Planned Primary Pars Plana Vitrectomy (PPV) ocriplasmin - Vitrectomy | Phase 2 | Completed | ThromboGenics | 38 | 2010-07-01 | 2014-12-17 |
| Clinical Trial of Intravitreal Microplasmin in Infants and Children Scheduled for Vitrectomy Ocriplasmin, Placebo - Vitrectomy | Phase 2 | Completed | ThromboGenics | 24 | 2010-02-01 | 2014-12-17 |
| Safety and Efficacy Study of Intravitreal Ocriplasmin in Subjects With AMD With Focal Vitreomacular Adhesion Ocriplasmin, Sham injection - Exudative Age-Related Macular Degeneration, Focal Vitreomacular Adhesion | Phase 2 | Completed | ThromboGenics | 100 | 2010-01-01 | 2014-12-17 |
| Safety and Efficacy Study of Microplasmin in for Non-Surgical Treatment of Focal Vitreomacular Adhesion Microplasmin - Focal Vitreomacular Adhesion | Phase 2 | Completed | ThromboGenics | 17 | 2010-01-01 | 2014-04-07 |
| Study of Intravitreal Microplasmin in Relieving Vitreo-Macular Adhesion in Neovascular Age-related Macular Degeneration Microplasmin, Placebo control - Macular Degeneration | Phase 2 | Unknown | University of California, Los Angeles | 30 | 2009-10-01 | 2011-09-27 |
| Single Intravenous Administration of TB-402 for the Prophylaxis of Venous Thromboembolic Events (VTE) After Total Knee Replacement Surgery TB-402, Enoxaparin - Total Knee Replacement Surgery | Phase 2 | Completed | ThromboGenics | 316 | 2008-12-01 | 2014-04-07 |
| Microplasmin Administered Via the Trellis-8 Infusion System for Treatment of Acute Iliofemoral DVT microplasmin - Deep Vein Thrombosis | Phase 2 | Terminated | ThromboGenics | 6 | 2007-03-01 | 2014-04-07 |
| A Study to Compare Multiple Doses Intravitreal Microplasmin for Treatment of Patients With Vitreomacular Traction (MIVI-IIt) ocriplasmin, Sham Comparator - Vitreomacular Traction | Phase 2 | Completed | ThromboGenics | 60 | 2007-02-01 | 2014-12-17 |
| A Multicenter Study to Compare Multiple Doses of Intravitreal Microplasmin Versus Sham Injection for Treatment of Patients With Diabetic Macular Edema (DME) ocriplasmin, Sham injection - Diabetic Macular Edema | Phase 2 | Completed | ThromboGenics | 51 | 2006-12-01 | 2014-12-17 |
| A Study of the Safety and Efficacy of Microplasmin to Induce a Posterior Vitreous Detachment (MIVI III) Ocriplasmin 25µg, Ocriplasmin 75µg, Ocriplasmin 125µg - Vitrectomy | Phase 2 | Completed | ThromboGenics | 125 | 2006-12-01 | 2014-12-17 |
| Intra-arterial Microplasmin Administration in Patients With Acute Intracranial Vertebrobasilar Artery Occlusion Microplasmin - Stroke | Phase 2 | Terminated | ThromboGenics | 2 | 2006-12-01 | 2014-04-07 |
| Intravenous Administration of Microplasmin for Treatment of Acute Ischemic Stroke Microplasmin - Stroke, Acute | Phase 2 | Completed | ThromboGenics | 40 | 2005-10-01 | 2014-11-07 |
| Intra-arterial Microplasmin Administration in Patients With Acute Peripheral Arterial Occlusion Microplasmin - Arterial Occlusive Diseases | Phase 2 | Terminated | ThromboGenics | 19 | 2005-03-01 | 2014-04-07 |
| Intravitreal Microplasmin in Patients Undergoing Surgical Vitrectomy Microplasmin - Vitreomacular Traction Maculopathy, Eye Diseases | Phase 2 | Completed | ThromboGenics | 60 | 2004-12-01 | 2014-04-07 |
Diabetic Retinopathy (3) · Macular Degeneration (2) · Stroke (2) · Arterial Occlusive Diseases (1) · Disease Progression (1) · Eye Diseases (1) · Idiopathic Juxtafoveal Retinal Telangiectasia (1) · Ischemic Stroke (1) · Macular Edema (1) · Retinal Perforations (1) · Retinal Telangiectasis (1) · Thromboembolism (1) · Venous Thrombosis (1) · Vitreous Detachment (1)
microplasmin (14) · salicylhydroxamic acid (3) · TB 402 (2) · Enoxaparin (1) · Eplerenone (1) · Rivaroxaban (1) · TB-403 (1)
Belgium (9) · Germany (6) · United States (6) · Netherlands (4) · France (3) · Hungary (3) · Italy (3) · United Kingdom (3) · Austria (2) · Bulgaria (2) · Czechia (2) · Israel (2) · Latvia (2) · Poland (2) · Russia (2)
Gerard O'Sullivan, MD (1) · Gerhard Hamann, Prof. Dr (1) · Peter Verhamme, MD, PhD (1) · Steven D Schwartz, M.D. (1) · Vincent Thijs, MD PhD (1)
2015 (1), 2016 (1), 2017 (1)